Related references
Note: Only part of the references are listed.Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or Sirolimus-Eluting Stents
Rainer Hoffmann et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents
Htut K. Win et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Effect of lipid levels and lipid-lowering therapy on Restenosis after coronary artery stenting
Stamatios Lerakis et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2006)
Metabolic syndrome - Risk factor distribution and 18-year mortality in the multiple risk factor intervention trial
LE Eberly et al.
DIABETES CARE (2006)
Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus
PWF Wilson et al.
CIRCULATION (2005)
Diagnosis and management of the metabolic syndrome - An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement
SM Grundy et al.
CIRCULATION (2005)
Obesity and clinical restenosis after coronary stent placement
JS Rana et al.
AMERICAN HEART JOURNAL (2005)
Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention
J Wouterjukema et al.
DIABETES CARE (2005)
Predictive factors for ischemic target vessel revascularization in the Prevention of Restenosis with Tranilast and its Outcomes (PRESTO) trial
M Singh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease
GR Dagenais et al.
AMERICAN HEART JOURNAL (2005)
Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women - A report from the Women's Ischemia Syndrome Evaluation
OC Marroquin et al.
CIRCULATION (2004)
The metabolic syndrome and risk of major coronary events in the Scandinavian simvastatin survival study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)
CJ Girman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2004)
Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey
JK Ninomiya et al.
CIRCULATION (2004)
Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults
S Malik et al.
CIRCULATION (2004)
Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?
PM Ridker et al.
CIRCULATION (2004)
Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study
N Sattar et al.
CIRCULATION (2003)
C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events
PM Ridker et al.
CIRCULATION (2003)
Clinical restenosis after coronary stenting: Perspectives from multicenter clinical trials
DE Cutlip et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox)
HS Gurm et al.
AMERICAN JOURNAL OF CARDIOLOGY (2002)
Clinical and angiographic determinants of adverse cardiac events in patients with stent restenosis
LC Chen et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2002)
Abdominal and total adiposity and risk of coronary heart disease in men
KM Rexrode et al.
INTERNATIONAL JOURNAL OF OBESITY (2001)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
